Member Info for Jimzi

they will only cash out of the CL element - they will keep the main holding - see northlands $1b mcap for 2018?? - see other bb Just don't understand peeps being so impatient by selling when this case is a no brainer -and you have a free Datatern lottery ticket - which could be huge. Still, each to their own

cause it means ipriclam is working - they are obliged to report any problems. I think the experts know it works really. Another thought, our Datatern copiers may realise that if AMP suddenly has a very strong balance sheet with 36% of MTFB [on Nasdaq] they may be more minded to settle. Then it gets exciting

the longer MTFB goes with no clincial news the better [within reason] as pointed out by Ivy - our resident pharma expert. I hadn't realised that until it was pointed out - so this lack of clinical news plus todays Nasdaq RNS - which could be quite quick, bodes well

Got 36% with the CL. They will convert, cash in that bit on Nasdaq - co totally debt free and cashed up and keep the 26% for the popper imo I think the supply is from the estate of the director who passed on - IHT etc?? -

Yep, easiest arbitrage ever imo

you clearly missed the 55m dump a couple of days ago - JPM prob

Yep, that makes sense now MTFB was all over the place &- forgot about KMK.

It was 12p - interims. Journalism

NAV was 12p [sept 15] and Dec 14 it was 7p Finals now 3.8p [today] I can't reconcile this v big drop

nothing on MOU. Not alot of news at all, bit disappointed really

Nah, he's keen and quite right. Clearly followed MTFB rise - I just think we have a very slow seller here via CFEP, like today, ask is 75 but last deal near 4. - albeit small Good news is it is just a trickle seller

http://www.bloomberg.com/research/stocks/people/person.asp?personId=111235&privcapId=105084

http://www.forbes.com/forbes/2001/0611/142.html

MTFB almost certainly will Nasdaq list and boom- AMP will follow, its a mathematical certainty - we effectively own over one third of the bugger. Why someone wants to keep it here, I don't know but they can't control the company assets.- and forget graphs, it will be a linear move in relation to the mcap of MTFB [plus news on m2m of course]

the pennies dropping.

On 1 April 2015, Amphion Innovations plc converted US $6,000,000 of notes and accrued interest into shares of Motif BioSciences Inc. Convertible promissory notes were issued for Amphion Innovations plc's remaining balance of $1,471,700 and Amphion Innovations US Inc.'s balance of US $2,079,086 that include unpaid accrued interest and advisory and consultancy fees. The new notes which accrue interest at the rate of 7% per annum, mature on 31 December 2016 and can be converted into ordinary shares of Motif Bio plc at the rate of US $0.1758 per share. Roughly 20m shares From MTFB interims

It will soon mate and probably it will be sudden Watch them covert and use them for nasdaq shares - from 0.17c to ???? [and they retain the 26.8%] Its a no brainer [and the free float here is not too large - alot in sticky hands imo

10 mins later, someone does a sell fill or kill for 75k! when MTFB looks stronger.. Why wait to sell today? Nout so queer as folk!

MTFB RNS points very heavily to a Nasdaq listing - and peeps still sell and L2 made to look weak. The disconnect will not last for ever

Its undervalued - m2m merger news soon and that could be large. Funded and debt secured by KMK and MTFB at good rates - AMP will own 36.6% post CL conversion [fully diluted] - I posted a detailed calc about 6 months ago on this bb And the lotto ticket of Datatern. timing of which is unknown - tomorrow or 1 year but a 50% lotto ticket with winnings to match Its just a boring share sp wise as it awaits events - but not alot priced in at the mo imo and the BOD are A1